The January 2014 PASRR webinar "Level I PASRR Screens: Best Practices for a Robust System" occured on Tuesday, January 14th, at 1 PM EST (10 AM PST).
You can download a PDF version of the presentation slides here and at the bottom of this webpage.
The webinar was led by Dr. Ed Kako, Director of the PASRR Technical Asisstance Center (PTAC) and Dan Timmel, PASRR policy director at the Centers for Medicare and Medicaid Services.
Synopsis of the Topic:
Federal regulations relating to the Preadmission Screening and Resident Review (PASRR) program require that all individuals applying for admission to a nursing home be screened for the possibility of mental illness (MI) or intellectual disability (ID). This process has two "levels": Level I, a preliminary screen whose purpose is to identify individuals who *may* have MI/ID; and Level II, an in-depth evaluation whose purpose is to identify individuals who do have MI/ID and to recommend a set of disability-specific services.
While federal regulations specify the requirements for a Level II in some detail, they are nearly silent about the requirements for a Level I. This has led to tremendous variation among states in the design of Level I tools, and in the requirements for personnel who administer the tools. As a result, Level I tools may under-identify the set of individuals who need a Level II evaluation.
The purpose of this webinar is to explain how Level I screens fit into the overall PASRR process; to describe Level I screens as needing to strike a balance between effectiveness (accuracy) and cost; and to identify the characteristics of a model Level I tool and system.
Dr. Ed Kako is the Director of the PASRR Technical Assistance Center (PTAC) and has several years of experience providing technical assistance around PASRR policy.
Dan Timmel is the PASRR policy director at the Centers for Medicare and Medicaid Services (CMS). Dan has twenty years of experience in public health and clinical social work including a period of teaching at the University of Maryland School of Medicine.
Acknowledgement of Commercial Support
There was no commercial support received for this CME activity.
Objectives - After attending this program, participants should be able to:
- Explain purpose of Level I screens within the PASRR process.
- Describe the tradeoffs in Level I screens between effectiveness/efficiency and cost/resources.
- Identify the characteristics of a model Level I screen.
Bibliographic Sources: Please see presentation slides
Copyright: All faculties in this activity have given their permission for publication.
© 2014 Mission Analytics Group, LLC